Searching for just a few words should be enough to get started. If you need to make more complex queries, use the tips below to guide you.
Article type: Research Article
Authors: Sokolova, Irina A. | Muravyov, Alexei V. | Khokhlova, Maria D. | Rikova, Sofya Yu. | Lyubin, Evgeny V. | Gafarova, Marina A. | Skryabina, Maria N. | Fedyanin, Angrey A. | Kryukova, Darya V. | Shahnazarov, Alexander A.
Affiliations: Institute of Mechanics, Lomonosov Moscow State University, Moscow, Russia | Department of Medicine and Biology, Pedagogical University, Yaroslavl, Russia | Faculty of Physics, Lomonosov Moscow State University, Moscow, Russia | Faculty of Basic Medicine, Lomonosov Moscow State University, Moscow, Russia
Note: [] Corresponding author: Alexei V. Muravyov, Department of Medicine and Biology, Pedagogical University, Yaroslavl, Russia. E-mail: alexei.47@mail.ru
Abstract: The reversible aggregation of red blood cells (RBCs) continues to be of the basic science and clinical interest. Recently it has been reported about a specific binding between fibrinogen and unknown erythrocyte glycoprotein receptors. The aim of this study was to investigate whether the red blood cell aggregation (RBCA) include the cell-cell interaction using the membrane receptors that bind such ligands as fibrinogen or fibronectin. To test this hypothesis the RBCs were incubated with monafram - the drug of the monoclonal antibodies against glycoprotein (GP) IIb/IIIa, with the GPIIb-IIIa receptor antagonist tirofiban, epifibatide and with the fibrinogen inhibiting peptide. It has been found that the RBC incubation with monafram resulted in a marked RBCA decrease mainly in persons with high level of aggregation. Another research session has shown that RBC incubation with fibronectin was accompanied by a significant RBCA rise. The monafram addition to red cell incubation medium resulted in a significant RBCA lowering. The cell incubation with tirofiban and epifibatide issued in RBCA decrease. The similar results were obtained when RBCs were incubated with the fibrinogen inhibiting peptide. Although monafram, tirofiban, eptifibatide and the fibrinogen inhibiting peptide were related to fibrinogen function they didn't inhibit RBCA completely. Therefore, under moderate and low red blood cell aggregation the cell binding is probably related to nonspecific mode. It seems evident that the specific and nonspecific modes of red blood cell aggregate formation could co-exist. Additional theoretical and experimental investigations in this area are needed.
Keywords: Red blood cells, aggregation, bridging model, glycoprotein (GP) IIb/IIIa receptors, fibrinogen, fibronectin, monafram, eptifibatide, tirofiban
DOI: 10.3233/CH-131774
Journal: Clinical Hemorheology and Microcirculation, vol. 57, no. 3, pp. 291-302, 2014
IOS Press, Inc.
6751 Tepper Drive
Clifton, VA 20124
USA
Tel: +1 703 830 6300
Fax: +1 703 830 2300
sales@iospress.com
For editorial issues, like the status of your submitted paper or proposals, write to editorial@iospress.nl
IOS Press
Nieuwe Hemweg 6B
1013 BG Amsterdam
The Netherlands
Tel: +31 20 688 3355
Fax: +31 20 687 0091
info@iospress.nl
For editorial issues, permissions, book requests, submissions and proceedings, contact the Amsterdam office info@iospress.nl
Inspirees International (China Office)
Ciyunsi Beili 207(CapitaLand), Bld 1, 7-901
100025, Beijing
China
Free service line: 400 661 8717
Fax: +86 10 8446 7947
china@iospress.cn
For editorial issues, like the status of your submitted paper or proposals, write to editorial@iospress.nl
如果您在出版方面需要帮助或有任何建, 件至: editorial@iospress.nl